{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:46Z","timestamp":1740107206728,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:00:00Z","timestamp":1612051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:00:00Z","timestamp":1612051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00405-020-06593-5","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T10:02:25Z","timestamp":1612087345000},"page":"3333-3344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A network meta-analysis for efficacies and toxicities of different therapeutic regimens in the treatment of advanced nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"278","author":[{"given":"Tingyu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kening","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7314-3027","authenticated-orcid":false,"given":"Lijie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,31]]},"reference":[{"key":"6593_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13277-014-2847-3","volume":"36","author":"G Tan","year":"2015","unstructured":"Tan G, Tang X, Tang F (2015) The role of microRNAs in nasopharyngeal carcinoma. Tumour Biol 36:69\u201379","journal-title":"Tumour Biol"},{"key":"6593_CR2","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.ejca.2015.05.025","volume":"51","author":"PY Huang","year":"2015","unstructured":"Huang PY, Zeng Q, Cao KJ et al (2015) Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: a single-institution experience from an endemic area. Eur J Cancer 51:1760\u20131770","journal-title":"Eur J Cancer"},{"key":"6593_CR3","doi-asserted-by":"publisher","first-page":"11309","DOI":"10.1038\/ncomms11309","volume":"7","author":"M Zhao","year":"2016","unstructured":"Zhao M, Luo R, Liu Y et al (2016) miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K\/AKT-c-JUN. Nat Commun 7:11309","journal-title":"Nat Commun"},{"key":"6593_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3892\/mco.2013.75","volume":"1","author":"C Xiao","year":"2013","unstructured":"Xiao C, Wang L, Jiao Y et al (2013) Long-term results of concurrent chemoradiotherapy for T3\/T4 locally advanced nasopharyngeal carcinoma. Mol Clin Oncol 1:507\u2013510","journal-title":"Mol Clin Oncol"},{"key":"6593_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0360-3016(00)00778-1","volume":"48","author":"JS Cooper","year":"2000","unstructured":"Cooper JS (2000) Concurrent chemotherapy and radiation therapy for advanced stage carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 48:1277\u20131279","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6593_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/mt.2013.242","volume":"22","author":"WK Chia","year":"2014","unstructured":"Chia WK, Teo M, Wang WW et al (2014) Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and\/or locally recurrent nasopharyngeal carcinoma. Mol Ther 22:132\u2013139","journal-title":"Mol Ther"},{"key":"6593_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00066-015-0904-5","volume":"191","author":"M Becker-Schiebe","year":"2015","unstructured":"Becker-Schiebe M, Christiansen H (2015) Update on combined radio-, radiochemo-, and chemotherapy alone in multimodal therapy of nasopharyngeal carcinoma\u2013a MAC-NPC meta-analysis. Strahlenther Onkol 191:991\u2013993","journal-title":"Strahlenther Onkol"},{"key":"6593_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1259\/bjr\/72813246","volume":"82","author":"CY Chen","year":"2009","unstructured":"Chen CY, Han F, Zhao C et al (2009) Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone. Br J Radiol 82:452\u2013458","journal-title":"Br J Radiol"},{"key":"6593_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.radonc.2013.10.020","volume":"110","author":"X Sun","year":"2014","unstructured":"Sun X, Su S, Chen C et al (2014) Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol 110:398\u2013403","journal-title":"Radiother Oncol"},{"key":"6593_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ctrv.2009.01.002","volume":"35","author":"H Lu","year":"2009","unstructured":"Lu H, Peng L, Yuan X et al (2009) Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia. Cancer Treat Rev 35:345\u2013353","journal-title":"Cancer Treat Rev"},{"key":"6593_CR11","doi-asserted-by":"publisher","first-page":"24835","DOI":"10.1038\/srep24835","volume":"6","author":"H Peng","year":"2016","unstructured":"Peng H, Chen L, Zhang Y et al (2016) The tumour response to induction chemotherapy has prognostic value for long-term survival outcomes after intensity-modulated radiation therapy in nasopharyngeal carcinoma. Sci Rep 6:24835","journal-title":"Sci Rep"},{"key":"6593_CR12","doi-asserted-by":"publisher","first-page":"e2667","DOI":"10.1097\/MD.0000000000002667","volume":"95","author":"C Chen","year":"2016","unstructured":"Chen C, Zhang M, Xu Y et al (2016) Unidimensional measurement may evaluate target lymph nodal response after induction chemotherapy for nasopharyngeal carcinoma. Med (Baltim) 95:e2667","journal-title":"Med (Baltim)"},{"key":"6593_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.ejca.2015.04.027","volume":"51","author":"M Yan","year":"2015","unstructured":"Yan M, Kumachev A, Siu LL, Chan KK (2015) Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: a Bayesian network meta-analysis. Eur J Cancer 51:1570\u20131579","journal-title":"Eur J Cancer"},{"key":"6593_CR14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"6593_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4111\/kju.2013.54.5.289","volume":"54","author":"JH Chung","year":"2013","unstructured":"Chung JH, Lee SW (2013) Assessing the quality of randomized controlled urological trials conducted by korean medical institutions. Korean J Urol 54:289\u2013296","journal-title":"Korean J Urol"},{"key":"6593_CR16","doi-asserted-by":"publisher","first-page":"e0123153","DOI":"10.1371\/journal.pone.0123153","volume":"10","author":"LX Chen","year":"2015","unstructured":"Chen LX, Li YL, Ning GZ et al (2015) Comparative efficacy and tolerability of three treatments in old people with osteoporotic vertebral compression fracture: a network meta-analysis and systematic review. PLoS ONE 10:e0123153","journal-title":"PLoS ONE"},{"key":"6593_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-051X.2011.01844.x","volume":"39","author":"YK Tu","year":"2012","unstructured":"Tu YK, Needleman I, Chambrone L, Lu HK, Faggion CM Jr (2012) A Bayesian network meta-analysis on comparisons of enamel matrix derivatives, guided tissue regeneration and their combination therapies. J Clin Periodontol 39:303\u2013314","journal-title":"J Clin Periodontol"},{"key":"6593_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/apt.13122","volume":"41","author":"GQ Zhu","year":"2015","unstructured":"Zhu GQ, Shi KQ, Huang S et al (2015) Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy. Aliment Pharmacol Ther 41:624\u2013635","journal-title":"Aliment Pharmacol Ther"},{"key":"6593_CR19","doi-asserted-by":"publisher","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","volume":"8","author":"A Chaimani","year":"2013","unstructured":"Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G (2013) Graphical tools for network meta-analysis in STATA. PLoS ONE 8:e76654","journal-title":"PLoS ONE"},{"key":"6593_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP (2011) Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 64:163\u2013171","journal-title":"J Clin Epidemiol"},{"key":"6593_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","volume":"13","author":"L Chen","year":"2012","unstructured":"Chen L, Hu CS, Chen XZ et al (2012) Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol 13:163\u2013171","journal-title":"Lancet Oncol"},{"key":"6593_CR22","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/jnci\/djr432","volume":"103","author":"QY Chen","year":"2011","unstructured":"Chen QY, Wen YF, Guo L et al (2011) Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst 103:1761\u20131770","journal-title":"J Natl Cancer Inst"},{"key":"6593_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/annonc\/mdr116","volume":"23","author":"G Fountzilas","year":"2012","unstructured":"Fountzilas G, Ciuleanu E, Bobos M et al (2012) Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation. Ann Oncol 23:427\u2013435","journal-title":"Ann Oncol"},{"key":"6593_CR24","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.oraloncology.2012.04.006","volume":"48","author":"PY Huang","year":"2012","unstructured":"Huang PY, Cao KJ, Guo X et al (2012) A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Oral Oncol 48:1038\u20131044","journal-title":"Oral Oncol"},{"key":"6593_CR25","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/jnci\/djq258","volume":"102","author":"AW Lee","year":"2010","unstructured":"Lee AW, Tung SY, Chua DT et al (2010) Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 102:1188\u20131198","journal-title":"J Natl Cancer Inst"},{"key":"6593_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1186\/s12885-015-1768-x","volume":"15","author":"WF Li","year":"2015","unstructured":"Li WF, Li YQ, Chen L et al (2015) Propensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy. BMC Cancer 15:810","journal-title":"BMC Cancer"},{"key":"6593_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3857\/roj.2015.33.2.98","volume":"33","author":"CW Wee","year":"2015","unstructured":"Wee CW, Keam B, Heo DS et al (2015) Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy. Radiat Oncol J 33:98\u2013108","journal-title":"Radiat Oncol J"},{"key":"6593_CR28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.oraloncology.2011.03.008","volume":"47","author":"T Xu","year":"2011","unstructured":"Xu T, Hu C, Wang X, Shen C (2011) Role of chemoradiotherapy in intermediate prognosis nasopharyngeal carcinoma. Oral Oncol 47:408\u2013413","journal-title":"Oral Oncol"},{"key":"6593_CR29","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.18632\/oncotarget.6754","volume":"7","author":"L Zhang","year":"2016","unstructured":"Zhang L, Tang LQ, Chen QY et al (2016) Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy. Oncotarget 7:6221\u20136230","journal-title":"Oncotarget"},{"key":"6593_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/jjco\/hyv192","volume":"46","author":"Q Guo","year":"2016","unstructured":"Guo Q, Lu T, Lin S et al (2016) Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era. Jpn J Clin Oncol 46:241\u2013247","journal-title":"Jpn J Clin Oncol"},{"key":"6593_CR31","doi-asserted-by":"publisher","first-page":"33408","DOI":"10.18632\/oncotarget.8573","volume":"7","author":"PY OuYang","year":"2016","unstructured":"OuYang PY, Shi D, Sun R et al (2016) Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma. Oncotarget 7:33408\u201333417","journal-title":"Oncotarget"},{"key":"6593_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","volume":"104","author":"G Peng","year":"2012","unstructured":"Peng G, Wang T, Yang KY et al (2012) A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 104:286\u2013293","journal-title":"Radiother Oncol"},{"key":"6593_CR33","doi-asserted-by":"publisher","first-page":"e0154501","DOI":"10.1371\/journal.pone.0154501","volume":"11","author":"MY Wu","year":"2016","unstructured":"Wu MY, He XY, Hu CS (2016) Tumor Regression and Patterns of Distant Metastasis of T1\u2013T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy. PLoS ONE 11:e0154501","journal-title":"PLoS ONE"},{"key":"6593_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.radonc.2012.08.001","volume":"104","author":"AW Lee","year":"2012","unstructured":"Lee AW, Ng WT, Chan YH et al (2012) The battle against nasopharyngeal cancer. Radiother Oncol 104:272\u2013278","journal-title":"Radiother Oncol"},{"key":"6593_CR35","doi-asserted-by":"publisher","first-page":"e56208","DOI":"10.1371\/journal.pone.0056208","volume":"8","author":"X Ji","year":"2013","unstructured":"Ji X, Xie C, Hu D et al (2013) Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma. PLoS ONE 8:e56208","journal-title":"PLoS ONE"},{"key":"6593_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard P, Lee A, Marguet S et al (2015) Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 16:645\u2013655","journal-title":"Lancet Oncol"},{"key":"6593_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lungcan.2004.03.004","volume":"46","author":"P Zatloukal","year":"2004","unstructured":"Zatloukal P, Petruzelka L, Zemanova M et al (2004) Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46:87\u201398","journal-title":"Lung Cancer"},{"key":"6593_CR38","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","volume":"23","author":"P Fournel","year":"2005","unstructured":"Fournel P, Robinet G, Thomas P et al (2005) Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: groupe Lyon-Saint-Etienne d\u2019Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95\u201301 Study. J Clin Oncol 23:5910\u20135917","journal-title":"J Clin Oncol"},{"key":"6593_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.radonc.2012.08.022","volume":"104","author":"AM Zhang","year":"2012","unstructured":"Zhang AM, Fan Y, Wang XX et al (2012) Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy. Radiother Oncol 104:279\u2013285","journal-title":"Radiother Oncol"},{"key":"6593_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/annonc\/mdu507","volume":"26","author":"YP Chen","year":"2015","unstructured":"Chen YP, Wang ZX, Chen L et al (2015) A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 26:205\u2013211","journal-title":"Ann Oncol"},{"key":"6593_CR41","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","volume":"23","author":"J Wee","year":"2005","unstructured":"Wee J, Tan EH, Tai BC et al (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer\/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23:6730\u20136738","journal-title":"J Clin Oncol"},{"key":"6593_CR42","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.clon.2016.01.012","volume":"28","author":"AB Miah","year":"2016","unstructured":"Miah AB, Bhide SA, Del Rosario L et al (2016) Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer. Clin Oncol (R Coll Radiol) 28:e61-67","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"6593_CR43","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/sim.1201","volume":"21","author":"T Lumley","year":"2002","unstructured":"Lumley T (2002) Network meta-analysis for indirect treatment comparisons. Stat Med 21:2313\u20132324","journal-title":"Stat Med"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-020-06593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-020-06593-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-020-06593-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T03:48:39Z","timestamp":1627962519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-020-06593-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,31]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["6593"],"URL":"https:\/\/doi.org\/10.1007\/s00405-020-06593-5","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"type":"print","value":"0937-4477"},{"type":"electronic","value":"1434-4726"}],"subject":[],"published":{"date-parts":[[2021,1,31]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest exist in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}